Joan Dorca

1.1k total citations
17 papers, 446 citations indexed

About

Joan Dorca is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Joan Dorca has authored 17 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Joan Dorca's work include Testicular diseases and treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Cells and Metastasis (3 papers). Joan Dorca is often cited by papers focused on Testicular diseases and treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Cells and Metastasis (3 papers). Joan Dorca collaborates with scholars based in Spain, Austria and United Kingdom. Joan Dorca's co-authors include Javier A. Menéndez, Begoña Martı́n-Castillo, Bruna Corominas-Faja, Sílvia Cufí, Joaquim Bosch‐Barrera, Cristina Oliveras‐Ferraros, Alejandro Vázquez‐Martín, Xavier García del Muro, Jorge Aparicio and A. Sáenz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Joan Dorca

17 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan Dorca Spain 8 245 214 147 139 75 17 446
Jae Y. Ro United States 9 142 0.6× 147 0.7× 110 0.7× 49 0.4× 64 0.9× 10 394
Mariana Cantante Portugal 13 252 1.0× 293 1.4× 65 0.4× 32 0.2× 129 1.7× 19 457
Keisuke Akaike Japan 14 107 0.4× 117 0.5× 140 1.0× 223 1.6× 44 0.6× 41 549
Tehmina Z. Ali United States 7 157 0.6× 109 0.5× 98 0.7× 112 0.8× 70 0.9× 12 427
Craig A. Rumpel United States 8 196 0.8× 124 0.6× 125 0.9× 24 0.2× 46 0.6× 8 425
Amy E. Schuster United States 9 232 0.9× 321 1.5× 43 0.3× 51 0.4× 38 0.5× 9 550
Lope Estévéz‐Schwarz Germany 10 148 0.6× 150 0.7× 83 0.6× 22 0.2× 46 0.6× 10 482
P Mondini Italy 14 98 0.4× 205 1.0× 186 1.3× 110 0.8× 91 1.2× 28 568
Ken-ichi Kawaguchi Japan 14 104 0.4× 184 0.9× 180 1.2× 122 0.9× 41 0.5× 20 573
Ryuzo Ueda Japan 7 125 0.5× 86 0.4× 142 1.0× 28 0.2× 13 0.2× 10 364

Countries citing papers authored by Joan Dorca

Since Specialization
Citations

This map shows the geographic impact of Joan Dorca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Dorca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Dorca more than expected).

Fields of papers citing papers by Joan Dorca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Dorca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Dorca. The network helps show where Joan Dorca may publish in the future.

Co-authorship network of co-authors of Joan Dorca

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Dorca. A scholar is included among the top collaborators of Joan Dorca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Dorca. Joan Dorca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pernas, Sònia, Aleix Prat, Octavio Burgués, et al.. (2017). AGATA molecular screening program: Implementing precision medicine in patients with advanced breast cancer in Spain. Annals of Oncology. 28. v104–v105. 1 indexed citations
2.
Martı́n-Castillo, Begoña, Eugeni López‐Bonet, Elisabet Cuyàs, et al.. (2015). Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas. Oncotarget. 6(32). 32317–32338. 29 indexed citations
3.
Martı́n-Castillo, Begoña, Eugeni López‐Bonet, María Buxó, et al.. (2015). Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant Basal-HER2 subtype of breast cancer. Oncotarget. 6(9). 7104–7122. 11 indexed citations
4.
5.
6.
Porta, Rut, Adriana Blancafort, Joan Dorca, et al.. (2013). Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patients. Menopause The Journal of The North American Menopause Society. 21(2). 188–191. 13 indexed citations
7.
Cufí, Sílvia, Bruna Corominas-Faja, Eugeni López‐Bonet, et al.. (2013). Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin. Oncotarget. 4(9). 1484–1495. 28 indexed citations
8.
Cufí, Sílvia, Bruna Corominas-Faja, Alejandro Vázquez‐Martín, et al.. (2012). Metformin-induced preferential killing of breast cancer initiating CD44+CD24−/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Oncotarget. 3(4). 395–398. 120 indexed citations
9.
Viñas, Gemma, Glòria Oliveras, Adriana Blancafort, et al.. (2012). Abstract P4-09-11: Fatty Acid Synthase (FASN) expression in Triple-Negative Breast Cancer. Cancer Research. 72(24_Supplement). P4–9. 3 indexed citations
10.
Colomer, Rámón, Ignasi Tusquets, Lourdes Calvo, et al.. (2006). Liposomal doxorubicin (M) plus gemcitabine (G) as first line treatment in metastatic breast carcinoma: A phase I-II study. Journal of Clinical Oncology. 24(18_suppl). 10651–10651. 2 indexed citations
11.
Aparicio, Jorge, J.R. Germà, Xavier García del Muro, et al.. (2005). Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study. Journal of Clinical Oncology. 23(34). 8717–8723. 134 indexed citations
12.
Ribot, Emeline J., et al.. (2005). Small Cell Lung Cancer and Cancer-Associated Retinopathy. Archivos de Bronconeumología. 41(2). 99–101. 5 indexed citations
13.
Ribot, Emeline J., et al.. (2005). Carcinoma broncogénico microcítico y retinopatía asociada a cáncer. Archivos de Bronconeumología. 41(2). 99–101. 8 indexed citations
14.
Aparicio, Jorge, Xavier García del Muro, Pablo Maroto, et al.. (2004). Risk-adapted management of stage I seminoma: The second Spanish Germ Cell Cancer Group (GG) study. Journal of Clinical Oncology. 22(14_suppl). 4518–4518. 5 indexed citations
15.
Aparicio, Jorge, Xavier García del Muro, Pablo Maroto, et al.. (2003). Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Annals of Oncology. 14(6). 867–872. 78 indexed citations
16.
Izquierdo, Á., P. Viladiu, Josep M. Borràs, et al.. (1996). [The risk of breast cancer in Catalonia].. PubMed. 107(11). 410–3. 5 indexed citations
17.
Fuentes, Rafael, E Canals, Jordi Vayreda, et al.. (1995). Neurological assessment of high grade astrocytomas following high dose radiotherapy as sole treatment. Clinical Oncology. 7(2). 110–112. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jae Y. Ro Breakdown of academic impact, for papers by Mariana Cantante Breakdown of academic impact, for papers by Keisuke Akaike Breakdown of academic impact, for papers by Tehmina Z. Ali Breakdown of academic impact, for papers by Craig A. Rumpel Breakdown of academic impact, for papers by Amy E. Schuster Breakdown of academic impact, for papers by Lope Estévéz‐Schwarz Breakdown of academic impact, for papers by P Mondini Breakdown of academic impact, for papers by Ken-ichi Kawaguchi Breakdown of academic impact, for papers by Ryuzo Ueda
Rankless by CCL
2026